1.
Neuregulin-4 (Nrg-4) as a Metabolic Regulator: A Comprehensive Review of Its Association with Dyslipidemia and Liver Function Abnormalities in Newly Diagnosed Type 2 Diabetes Mellitus. VER [Internet]. 2025 Dec. 10 [cited 2026 Jan. 15];8(19s):177-81. Available from: https://verjournal.com/index.php/ver/article/view/1430